Vitamin D supplementation - Is it only osteoprotection?;Suplementacja witamina̧ D - Czy tylko osteoprotekcja?

Przeglad Menopauzalny

Volumn 15, Issue 4, 2011, Pages 328-333

  Frankiewicz, Tadeusz ^a  

^a Osiedle Centrum B 5/1A   (Poland)

Author keywords

Calcitriol; Cholecalciferol; Extraskeletal effects; Vitamin D; Vitamin D deficiency

Indexed keywords

CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

BONE METABOLISM; CALCIUM HOMEOSTASIS; DISEASE PREDISPOSITION; MORTALITY; REVIEW; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 80052380078     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Holick M.F. Vitamin D: A D-Lightful health perspective. Nutr Rev 2008; 66: S182-S194
2. Wu S., Ren S., Nguyen L., et al. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 2007; 148: 3410-3418 (Pubitemid 46997000)
3. Van Etten E., Stoffels K., Gysemans C., et al. Regulation of vitamin D homeostasis: Implications for the immune system. Nutr Rev 2008; 66 (10 Suppl 2): S125-S134
4. Rook G.A., Steele J., Fraher L., et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163 (Pubitemid 16232232)
5. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773
6. Adams J.S., Ren S., Liu P.T., Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182: 4289-4295
7. Adorini L. Intervention in autoimmunity: The potential of vitamin D receptor agonists. Cell Immunol 2005; 233: 115-124 (Pubitemid 41074064)
8. Lemire J.M., Adams J.S., Sakai R., Jordan S.C. 1 alpha,25- dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-661 (Pubitemid 14054016)
9. Chen S., Sims G.P., Chen X.X., et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634-1647
10. Bhalla A.K., Amento E.P., Serog B., Glimcher L.H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 1984; 133: 1748-1754 (Pubitemid 14035260)
11. Mattner F., Smiroldo S., Galbiati F., et al. nhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 2000; 30: 498-508. (Pubitemid 30098842)
12. Boonstra A., Barrat F.J., Crain C., et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-4980 (Pubitemid 33009728)
13. Tang J., Zhou R., Luger D., et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009; 182: 4624-4632
14. Daniel C., Sartory N.A., Zahn N., et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33. (Pubitemid 350294165)
15. Almerighi C., Sinistro A., Cavazza A., et al. 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009; 45: 190-197
16. Urashima M., Segawa T., Okazaki M., et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91: 1255-1260
17. Munger K.L., Levin L.I., Hollis B.W., et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838 (Pubitemid 44969183)
18. Littorin B., Blom P., Schölin A., et al. Lower levels of plasma 25-hydroxy-vitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847-2852 (Pubitemid 44730286)
19. Merlino L.A., Curtis J., Mikuls T.R., et al. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-77 (Pubitemid 38084289)
20. Fronczak C.M., Barón A.E., Chase H.P., et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 2003; 26: 3237-3242 (Pubitemid 37466881)
21. Hyppönen E., Läärä E., Reunanen A., et al. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001; 358: 1500-1503 (Pubitemid 33055701)
22. Holick M.F. Vitamin D: Its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006; 92: 49-59. (Pubitemid 43831958)
23. Garland C., Shekelle R.B., Barrett-Connor E., et al. Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet 1985; 1: 307-309 (Pubitemid 15157126)
24. Garland F.C., Garland C.F., Gorham E.D., Young J.F. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation. Prev Med 1990; 19: 614-622
25. Lefkowitz E.S., Garland C.F. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994; 23: 1133-1136
26. Audo I., Darjatmoko S.R., Schlamp C.L., et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci 2003; 44: 4192-4199 (Pubitemid 37186250)
27. Bernardi R.J., Johnson C.S., Modzelewski R.A., Trump D.L. Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells. Endocrinology 2002; 143: 2508-2514 (Pubitemid 34701313)
28. Maruyama R., Toyota M., Suzuki H., et al. The functional relation of vitamin D receptor and p53 in cancer cells. Fifth AACR International Conference on Frontiers in Cancer Prevention Research 2006; 12-15.
29. Alvarez-Díaz S., Valle N., García J.M., et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest 2009; 119: 2343-2358
30. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003; 88: 327-331 (Pubitemid 36119906)
31. Krause R., Bühring M., Hopfenmüller W., et al. Ultraviolet B and blood pressure. Lancet 1998; 352: 709-710 (Pubitemid 28398716)
32. Pfeifer M., Begerow B., Minne H.W., et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-1637 (Pubitemid 32377290)
33. Zittermann A., Schleithoff S.S., Tenderich G., et al. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003; 41: 105-112 (Pubitemid 36044411)
34. Schleithoff S.S., Zittermann A., Tenderich G., et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-759 (Pubitemid 44713136)
35. Eyles D.W., Smith S., Kinobe R., et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29: 21-30. (Pubitemid 39602785)
36. Puchacz E., Stumpf W.E., Stachowiak E.K., Stachowiak M.K. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res 1996; 36: 193-196 (Pubitemid 26058893)
37. Sonnenberg J., Luine V.N., Krey L.C., Christakos S. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology 1986; 118: 1433-1439 (Pubitemid 16078517)
38. Wion D., MacGrogan D., Neveu I., et al. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991; 28: 110-114
39. Naveilhan P., Neveu I., Wion D., Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996; 7: 2171-2175 (Pubitemid 26361840)
40. Neveu I., Naveilhan P., Baudet C., et al. 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 1994; 6: 124-126
41. Garcion E., Sindji L., Leblondel G., et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem 1999; 73: 859-866 (Pubitemid 29339862)
42. Cannell J.J. Autism and vitamin D. Med Hypotheses 2008; 70: 750-759 (Pubitemid 351318090)
43. Holick M.F. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
44. Holick M.F. Vitamin D: Extraskeletal health. Endocrinol Metab Clin North Am 2010; 39: 381-400.